Your browser doesn't support javascript.
Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls.
Kaddu-Mulindwa, Dominic; Thurner, Lorenz; Bewarder, Moritz; Murawski, Niels; Ahlgrimm, Manfred; Pfuhl, Thorsten; Gärtner, Barbara; Smola, Sigrun; Stilgenbauer, Stephan.
  • Kaddu-Mulindwa D; Department of Internal Medicine 1 (Oncology, Hematology, Rheumatology and Clinical Immunology), Saarland University Medical Center, Kirrberger Str. 100, 66421, Homburg, Germany. dominic.kaddu@uks.eu.
  • Thurner L; Department of Internal Medicine 1 (Oncology, Hematology, Rheumatology and Clinical Immunology), Saarland University Medical Center, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Bewarder M; Department of Internal Medicine 1 (Oncology, Hematology, Rheumatology and Clinical Immunology), Saarland University Medical Center, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Murawski N; Department of Internal Medicine 1 (Oncology, Hematology, Rheumatology and Clinical Immunology), Saarland University Medical Center, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Ahlgrimm M; Department of Internal Medicine 1 (Oncology, Hematology, Rheumatology and Clinical Immunology), Saarland University Medical Center, Kirrberger Str. 100, 66421, Homburg, Germany.
  • Pfuhl T; Institute of Virology, Saarland University Medical Center, 66421, Homburg, Germany.
  • Gärtner B; Institute of Medical Microbiology and Hygiene, Saarland University Medical Center, 66421, Homburg, Germany.
  • Smola S; Institute of Virology, Saarland University Medical Center, 66421, Homburg, Germany.
  • Stilgenbauer S; Department of Internal Medicine 1 (Oncology, Hematology, Rheumatology and Clinical Immunology), Saarland University Medical Center, Kirrberger Str. 100, 66421, Homburg, Germany.
Infect Agent Cancer ; 16(1): 17, 2021 Feb 24.
Article in English | MEDLINE | ID: covidwho-1102344
ABSTRACT
Due to the worldwide COVID-19 outbreak it is mandatory for health care workers to develop containment strategies. Recently published data showed, that cancer patients might have a higher risk for severe course of the disease. We therefore developed a strategy of screening and containment for SARS-CoV-2 for hospitalized cancer patients. Our approach includes a temporary isolation in a so-called floating zone and testing strategy for screening of asymptomatic individuals by pooling of samples before RT-PCR amplification. Patients as far as health care professionals got tested twice a week. Nurses and physicians entered the floating zone with full body protection. Within 8 weeks we tested 418 individuals (professionals and patients) in total. Only 2 patients had COVID-19 without documented further transmission of SARS-CoV-2. We therefore think that our strategy might be a useful approach to protect inpatients with cancer at high risk for SARS-CoV-2 infection during this ongoing pandemic.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Infect Agent Cancer Year: 2021 Document Type: Article Affiliation country: S13027-021-00356-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Infect Agent Cancer Year: 2021 Document Type: Article Affiliation country: S13027-021-00356-5